Clinical Trial Details

< Previous Trial     Next Trial >
Study ID 08-046
Title Stereotactic Body Radiotherapy for Head and Neck Tumors
Conditions Squamous Cell Carcinoma of the Head and Neck
Nasopharyngeal Carcinoma
Salivary Gland Cancer
Head and Neck Sarcoma
Paraganglioma of Head and Neck
Chordoma of Head and Neck
Chondrosarcoma of Head and Neck
Angiofibroma of Head and Neck
Interventions Radiation: stereotactic body radiotherapy
Radiation: Stereotactic body radiotherapy
Phase Phase 4
Purpose This study will evaluate the local control rates as well as acute and late toxicity rates of stereotactic body radiotherapy (SBRT) for the treatment of benign and malignant head and neck tumors.
Eligibility Ages Eligible: 18 Years
Genders Eligible:  Both
Accepts Healthy Volunteers:  No
Inclusion Criteria:
  • Patient age > 18 years
  • Zubrod performance status of 0-3
  • Benign head and neck tumors such as paragangliomas, chordoma, chondrosarcoma
  • Malignant head and neck cancers such as invasive squamous cell carcinoma, adenocarcinoma, nasopharyngeal carcinoma, salivary gland cancers, and sarcoma
  • Signed study-specific consent form Exclusion Criteria:
  • Pregnant or lactating women, due to potential exposure of the fetus to RT and unknown effects of RT on lactating females
  • Patients with psychiatric or addictive disorder that would preclude obtaining informed consent
  • Study Location N/A
    Contact N/A

    Information obtained from, on 7/30/2015. For additional information about this and other clinical trials, visit
    Please refer to this study by its identifier: NCT01344356

    Back to Search Results